Hemo Organic Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve 1. To consider and approve the Un-Audited Financial Results of the Company for the quarter and half year ended as on 30th September, 2025 along with the Limited Review Report thereon. 2. To consider and evaluate a proposal for raising funds through the issuance of one or more instruments, including equity shares, warrants convertible into equity shares, or other securities, by way of preferential issue, private placement or any other permissible mode(s), in accordance with the applicable provisions of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, and other applicable laws, subject to necessary approvals including approval of the shareholders and other statutory/regulatory authorities, as may be required. 3. To transact other businesses as per agenda being circulated.